Efficacy of MySkin Patch for the Healing of Burn Wounds: a Randomised Controlled Trial
1 other identifier
interventional
120
1 country
2
Brief Summary
Evaluation of clinical efficacy of my skin (hydrogel and polyurethane film) plus best practice clinical care in subjects with burn injuries with particular regard to: 1) Wound healing (complete reepithelialization), 2) the patient's pain. In the context of the study will be collected secondary outcomes related to type of lesion and its clinical evolution through the analysis of the items in the scale of the PSST.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
Started Jan 2012
Typical duration for phase_3
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 20, 2011
CompletedFirst Posted
Study publicly available on registry
December 26, 2011
CompletedStudy Start
First participant enrolled
January 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2014
CompletedJanuary 13, 2014
January 1, 2014
2.7 years
December 20, 2011
January 10, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Wound healing and Significant reduction in pain
1 month
Secondary Outcomes (1)
Clinical evaluation of the lesion scores for each visit, the presence / absence of infection for each visit
1 month
Study Arms (2)
MySkin patch
EXPERIMENTALHydrogel e polyurethane film
Traditional Dressing
ACTIVE COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- Presence of at least one injury burn covered by a dressing of 10x8 cm (80 cm2)
- Injury treated with medication in use at the center
- Patients assisted at the emergency care, or at the outpatient
- Extension of the lesion less than 80 cm2 (including dressings in cm10x8cm)
- Patient age greater than or equal to 18 years
- Patients who have given consent to enrollment in the trial and the processing of personal data
- Patient / lesion that has already been recruited in the study or who have previously passed a period of 10 days (washout) of "no treatment" according to the research protocol
You may not qualify if:
- A end-stage of disease
- Suspected or known allergic diathesis to the product of medication
- Subjects that do not give consent to data processing
- Dry lesion with necrosis or eschar
- Presence of both local and systemic infection or inflammation
- Injuries that to the decision of the provider of care, needs a targeted local treatment other than as provided for in the Protocol
- Patient / lesion that has already been previously recruited into the study, before a period of 10 days (washout) of suspension from the same research protocol
- Patients who use alternative medicine treatments such as aloe
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Istituto Clinico Humanitas - IRCCS
Rozzano, Milano, Italy
Ospedale di Circolo di Busto Arsizio
Busto Arsizio, Varese, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Patrizia Tomasin
Associazione Infermieristica per lo studio delle Lesioni Cutanee
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 20, 2011
First Posted
December 26, 2011
Study Start
January 1, 2012
Primary Completion
September 1, 2014
Study Completion
October 1, 2014
Last Updated
January 13, 2014
Record last verified: 2014-01